TSX:CDAY • US15677J1088
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CERIDIAN HCM HOLDING INC (CDAY.CA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-08-05 | Morningstar | Initiate | Buy |
| 2021-11-02 | Deutsche Bank | Initiate | Buy |
| 2021-08-05 | Piper Sandler | Maintains | Neutral |
| 2021-06-30 | Barclays | Downgrade | Equal-Weight -> Underweight |
| 2021-06-15 | Needham | Downgrade | Buy -> Hold |
| 2021-04-23 | Wolfe Research | Initiate | Outperform |
| 2021-04-09 | Barclays | Maintains | Equal-Weight |
| 2021-02-16 | BMO Capital | Upgrade | Market Perform -> Outperform |
| 2021-02-10 | Needham | Maintains | Buy |
| 2021-02-10 | Wells Fargo | Maintains | Overweight |
| 2021-02-10 | Credit Suisse | Maintains | Neutral |
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 842.5M 2.23% | 1.024B 21.57% | 1.246B 21.68% | 1.544B 23.90% | 1.774B 14.90% | 2.041B 15.05% | 2.434B 19.26% | 2.811B 15.49% | 3.219B 14.51% | 3.659B 13.67% | 4.129B 12.85% | |
| EBITDA YoY % growth | 56.9M -54.19% | 23.1M -59.40% | 54.7M 136.80% | 419.62M 667.13% | 501.72M 19.57% | 616.76M 22.93% | 842.52M 36.60% | 1.038B 23.20% | 1.254B 20.81% | 1.492B 18.98% | 1.748B 17.16% | |
| EBIT YoY % growth | 5.1M -92.40% | -54.4M -1,166.67% | -34.3M 36.95% | 341.29M 1,095.01% | 406.8M 19.19% | 510.72M 25.55% | 528.36M 3.45% | 610.98M 15.64% | 698.7M 14.36% | 792.54M 13.43% | 881.28M 11.20% | |
| Operating Margin | 0.61% | -5.31% | -2.75% | 22.10% | 22.93% | 25.02% | 21.71% | 21.74% | 21.71% | 21.66% | 21.34% | |
| EPS YoY % growth | 0.49 8.89% | 0.26 -46.94% | 0.77 196.15% | 1.36 76.11% | 1.72 26.67% | 2.15 25.46% | 3.68 70.88% | 4.56 23.82% | 5.52 21.03% | 6.57 19.04% | 7.69 17.08% |
All data in USD
| Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.33 43.63% | 0.45 45.59% | 0.42 29.73% | 0.44 17.59% | 0.42 26.70% | 0.54 19.01% | 0.51 22.60% | 0.55 25.32% | 0.51 22.31% |
| Revenue Q2Q % growth | 407.7M 21.30% | 436.86M 17.88% | 429.74M 17.45% | 442.5M 17.22% | 461.92M 13.30% | 496.41M 13.63% | 489.98M 14.02% | 511.36M 15.56% | 526.62M 14.01% |
| EBITDA Q2Q % growth | 100.58M 5.65% | 127.86M 99.78% | 121.33M 54.56% | 124.82M 8.35% | 123.89M 23.18% | 156.54M 22.43% | 151.07M 24.51% | 157.82M 26.44% | 149.11M 20.36% |
| EBIT Q2Q % growth | 77.805M 1,154.92% | 105.35M 151.43% | 99.957M 201.98% | 102.84M 230.68% | 100.56M 29.25% | 133.93M 27.13% | 129.32M 29.38% | 134.46M 30.75% | 125.98M 25.28% |
All data in USD
24 analysts have analysed CDAY.CA and the average price target is 105.21 CAD. This implies a price increase of 14.01% is expected in the next year compared to the current price of 92.28.
CERIDIAN HCM HOLDING INC (CDAY.CA) will report earnings on 2022-02-08.
The consensus EPS estimate for the next earnings of CERIDIAN HCM HOLDING INC (CDAY.CA) is 0.33 CAD and the consensus revenue estimate is 407.70M CAD.
The expected long term growth rate for CERIDIAN HCM HOLDING INC (CDAY.CA) is 17.44%.